Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic PatientsIsabelle Delattre, Pierre Wallemacq, Roger K. Verbeeck et al.|Therapeutic Drug Monitoring|2010Cited by 57
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacinIsabelle Delattre, Pierre Wallemacq, Fabio Silvio Taccone et al.|Clinical Biochemistry|2012Cited by 34
Empirical models for dosage optimization of four β-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacinIsabelle Delattre, Pierre Wallemacq, Jean‐Louis Vincent et al.|Clinical Biochemistry|2009Cited by 24